Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesFibromyalgia: Milnacipran: A New Treatment Option for Fibromyalgia
Practical Pain Management, 06/26/09
Mease PJ - On January 14, 2009 the Food and Drug Administration approved the use of SavellaTM (milnacipran) for the treatment of fibromyalgia. This third approved drug offers health care providers yet another treatment option for their fibromyaliga patients. Dr. Philip Mease’s detailed article covers the scientific specifics of Savella’s efficacy in a fibromyalgia treatment regimen and offers the promise of a better quality of life for people living with this chronic pain condition.
Related Articles
Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09
Relevance Score: 94%
Womens narratives on experiences of work ability and functioning in fibromyalgia
Musculoskeletal Care, 10/23/09
Relevance Score: 93%
General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study
BMC Public Health, 11/04/09
Relevance Score: 90%
Fibromyalgia: From treatment to rehabilitation
European Journal of Pain, 11/17/09
Relevance Score: 89%
Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention
Journal of Psychiatric and Mental Health Nursing, 11/16/09
Relevance Score: 89%
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/15/09
Catatonia and Its Treatment
Schizophrenia Bulletin, 12/15/09
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/15/09
Catatonia and Its Treatment
Schizophrenia Bulletin, 12/15/09
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Auditory Hallucinations in Dissociative Identity Disorder and Schizophrenia With and Without a Childhood Trauma History: Similarities and Differences
The Journal of Nervous and Mental Disease, 12/15/09
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies
Bipolar Disorders, 12/15/09
Effects of the GABA-reuptake Inhibitor Tiagabine on Panic and Anxiety in Patients with Panic Disorder
Pharmacopsychiatry, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor